"Nuclear Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
| Descriptor ID |
D009687
|
| MeSH Number(s) |
D12.776.660
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nuclear Proteins".
Below are MeSH descriptors whose meaning is more specific than "Nuclear Proteins".
This graph shows the total number of publications written about "Nuclear Proteins" by people in this website by year, and whether "Nuclear Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 14 | 3 | 17 |
| 1997 | 20 | 11 | 31 |
| 1998 | 16 | 9 | 25 |
| 1999 | 16 | 6 | 22 |
| 2000 | 22 | 9 | 31 |
| 2001 | 20 | 11 | 31 |
| 2002 | 23 | 8 | 31 |
| 2003 | 18 | 16 | 34 |
| 2004 | 23 | 19 | 42 |
| 2005 | 15 | 20 | 35 |
| 2006 | 13 | 6 | 19 |
| 2007 | 19 | 12 | 31 |
| 2008 | 16 | 13 | 29 |
| 2009 | 16 | 13 | 29 |
| 2010 | 16 | 3 | 19 |
| 2011 | 19 | 10 | 29 |
| 2012 | 15 | 10 | 25 |
| 2013 | 22 | 10 | 32 |
| 2014 | 12 | 18 | 30 |
| 2015 | 24 | 8 | 32 |
| 2016 | 18 | 15 | 33 |
| 2017 | 23 | 14 | 37 |
| 2018 | 18 | 14 | 32 |
| 2019 | 8 | 9 | 17 |
| 2020 | 14 | 12 | 26 |
| 2021 | 11 | 4 | 15 |
| 2022 | 4 | 9 | 13 |
| 2023 | 3 | 13 | 16 |
| 2024 | 4 | 9 | 13 |
| 2025 | 6 | 4 | 10 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nuclear Proteins" by people in Profiles.
-
Diffuse pediatric-type high grade glioma, RTK1 subtype, subclass C with SYN2::PPARG fusion in an older adult. CNS Oncol. 2026 12; 15(1):2641996.
-
Frequent synaptophysin expression in SMARCA4-deficient undifferentiated carcinoma of the oesophagus: a diagnostic pitfall with therapeutic implications. J Clin Pathol. 2026 Mar 19; 79(4):229-237.
-
Aberrant nuclear pore complex degradation contributes to neurodegeneration in VCP disease. Neuron. 2026 Mar 04; 114(5):850-867.e8.
-
Mutant p53 variants differentially impact replication initiation and activate cGAS-STING to affect immune checkpoint inhibition. Commun Biol. 2025 Nov 05; 8(1):1522.
-
Disparate leukemia mutations converge on nuclear phase-separated condensates. Cell. 2025 Dec 11; 188(25):7118-7136.e21.
-
The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in ADA, DCLRE1C, IL2RG, IL7R, JAK3, RAG1, and RAG2. Genet Med. 2026 Jan; 28(1):101613.
-
Further phenotypical delineation of DLG3-related neurodevelopmental disorders. Eur J Hum Genet. 2025 Dec; 33(12):1585-1595.
-
Synthesis, Structure-Activity Relationships, and Antitumor Activities of Quinoxiline-Containing Inhibitors of the Protein-Protein Interactions between Transcription Coactivator AF9/ENL and DOT1L/AF4. J Med Chem. 2025 Sep 25; 68(18):19396-19414.
-
?-catenin functions as a molecular adapter for disordered cBAF interactions. Mol Cell. 2025 Aug 21; 85(16):3041-3056.e9.
-
Recurrent de novo variants in the spliceosomal factor CRNKL1 are associated with severe microcephaly and pontocerebellar hypoplasia with seizures. Am J Hum Genet. 2025 Jul 03; 112(7):1722-1732.